0001593968-21-001513.txt : 20210602 0001593968-21-001513.hdr.sgml : 20210602 20210602212612 ACCESSION NUMBER: 0001593968-21-001513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210520 FILED AS OF DATE: 20210602 DATE AS OF CHANGE: 20210602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Andrew S. CENTRAL INDEX KEY: 0001770191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38847 FILM NUMBER: 21991052 MAIL ADDRESS: STREET 1: C/O SILK ROAD MEDICAL, INC. STREET 2: 1213 INNSBRUCK DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Silk Road Medical Inc CENTRAL INDEX KEY: 0001397702 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208777622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1213 INNSBRUCK DR. CITY: SUNNYVALE STATE: CA ZIP: 94089-2918 BUSINESS PHONE: 6505669060 MAIL ADDRESS: STREET 1: 1213 INNSBRUCK DR. CITY: SUNNYVALE STATE: CA ZIP: 94089-2918 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-05-20 0001397702 Silk Road Medical Inc SILK 0001770191 Davis Andrew S. C/O SILK ROAD MEDICAL, INC. 1213 INNSBRUCK DRIVE SUNNYVALE CA 94089 false true false false Chief Commercial Officer Common Stock 2021-06-01 4 M false 1657 1.6 A 32897 D Common Stock 2021-06-01 4 S false 1657 47.2264 D 31240 D Common Stock 2021-06-01 4 M false 4667 4.73 A 35907 D Common Stock 2021-06-01 4 S false 4667 47.2264 D 31240 D Common Stock 2021-05-20 5 A false E 420 40.38 A 31660 D Option (right to buy) 1.60 2021-06-01 4 M false 1657 0 D 2016-01-03 2025-12-03 Common Stock 1657 31475 D Option (right to buy) 4.73 2021-06-01 4 M false 4667 0 D 2017-09-01 2027-11-30 Common Stock 4667 79592 D The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020. This transaction was executed in multiple trades at price ranging from $46.67 to $48.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c). All of the shares subject to this option are fully vested and exercisable as of the date hereof. One forty-eighth of the shares subject to the option shall vest on September 1, 2017 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. /s/Mhairi Jones, by power of attorney 2021-06-02